Market Access
pricing and transparency

How transparent is the VPAG?

Leela Barham takes a look at the transparency of the UK’s new pricing and access scheme, the 2024 VPAG, based on public sources.

Sales & Marketing
UK launch market lobbying

Is the UK an attractive launch market?

Leela Barham tries to cut through the lobbying to identify objective measures of the attractiveness of the UK market for launching new medicines.